Indian Pharma Firm Develops Oral Vaccine In Capsule Form For
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
New forms of Covid-19 vaccine are now being developed by several pharma companies across the world. The latest is the oral Covid-19 vaccine in a capsule form that has been developed by Indian pharma company Premas Biotech.

A single dose of the Oravax Covid-19 capsule has been found effective and its efficacy has been proven in a pilot study on animals. Oravax’s oral vaccine promoted both systemic immunity by producing Neutralizing Antibodies (IgG) as well as (IgA) immune response, which protects the respiratory and gastrointestinal tracts against infection.

Premas’ protein-based VLP (Virus Like Particle) vaccine provides triple protection against three parts of the SARS CoV-2 virus i.e. Spike S, Membrane M, and Envelope E targets (but not against Nucleocapsid N antigen).

The VLPs in vaccine are manufactured using Premas’ proprietary D-Crypt platform while Oramed has world-leading oral protein delivery platform POD. An oral Covid-19 Oravax is a vaccine candidate that harnesses and combines the true potential of the two unique platforms.

Source:
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/indian-pharma-firm-develops-oral-vaccine-1782126-2021-03-22
s●●●●i a●●●n and 5 others like this
Like
Comment
Share